Structured around the specialty chemical squalene - typically derived from shark livers for use in used vaccines and cosmetics, SynShark is developing a method for extracting squalene from tobacco. Originally based in Texas (for Phase I) and subsequently relocated to Leland, NC, SynShark was, from the outse, anchored in the idea of re-inventing how science can address/solve the problem of scarce resources. Working with leading technologists, the Company early tackled the achievement of new plant pathways to channel photosynthesis energy towards terpene production, something native to the plant. The approach was to plant and harvest each year larger fields as bio manufacturers of ingredients without any post extraction conversion. Outcome: produce and supply high quality terpene oils - such as Tobacco Squalene - for the cosmetic and medical sectors. The firm's squalene plays an essential role in protecting the body from free radical oxidative damage. As a versatile personal care product which restores the skins suppleness, it is soft, silky and non greasy to the touch. Tobacco Squalene is the first of many cutting edge extracts and bio-actives that the firm plans to launch to replace unsustainable sourcing.
